RNA-directed targeting of AID in immunity and genomic integrity
RNA 引导的 AID 免疫和基因组完整性靶向
基本信息
- 批准号:9210606
- 负责人:
- 金额:$ 42.85万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-02-01 至 2021-01-31
- 项目状态:已结题
- 来源:
- 关键词:Adaptive Immune SystemAffectAffinityAlpha CellArchaeaB-Cell LymphomasB-LymphocytesBacteriaBindingBiochemicalCRISPR/Cas technologyCell DeathCell physiologyCellular biologyChromosomal translocationClustered Regularly Interspaced Short Palindromic RepeatsDNADNA DamageDNA Double Strand BreakDeaminaseDefectDevelopmentElementsEngineeringEnzymesFailureG-QuartetsGenerationsGenesGeneticGenetic TranscriptionGenomeGenome StabilityGenome engineeringGenomic SegmentGenomicsGrowthGuide RNAHeavy-Chain ImmunoglobulinsHumanHybridsImmune responseImmunityImmunoglobulin Class SwitchingImmunoglobulin GenesImmunoglobulin MImmunoglobulin Switch RecombinationImmunologic Deficiency SyndromesImpairmentKnock-inLeadLesionLymphomaLymphomagenesisMaintenanceMalignant NeoplasmsMature B-LymphocyteMediatingModelingMolecularMolecular ChaperonesMusMutationOncogenesOncogenicPatientsPhysiologicalPoint MutationProcessRNARNA BindingRNA SplicingRecruitment ActivityRestRoleShelter facilitySpecificityStructureSystemTestingToxic effectTranscriptUntranslated RNAactivation-induced cytidine deaminasebasedesignendonucleaseexperimental studygenome integritygenome-widein vitro testingin vivopreventpublic health relevancetooltumortumorigenesisvariable region gene
项目摘要
DESCRIPTION (provided by applicant): DNA double strand breaks (DSBs) constitute one of the most toxic lesions to occur in a cell. Unrepaired DSBs can either lead to cell death or can participate in chromosomal translocations that are hallmarks of many kinds of tumors, including lymphomas. Despite the toxicity associated with DSBs, during the immunoglobulin (Ig) gene diversification process of class switch recombination (CSR), DSBs are deliberately introduced into defined regions, called switch (S) regions, of the B cell genome, and a failure to introduce such DSBs leads to immunodeficiency syndromes. The DNA deaminase AID (activation induced cytidine deaminase) is essential for the generation of DSBs. While S regions (and the Ig gene associated variable region gene segments) are primary targets, AID has the potential to induce DSBs at non-Ig genes, including oncogenes. Such off-target DSBs are the major lesions behind the ontogeny of a large number of mature B cell lymphomas. Despite the relevance of AID targeting to both immunity and cancer, the molecular mechanisms underlying AID specificity are yet to be fully elucidated. We have now shown that noncoding RNA emanating from S regions act as molecular guides to recruit AID to S regions. This proposal tests the hypothesis that switch transcripts not only recruit AID to S regions to facilitate CSR but also sequester AID from other genomic regions to prevent collateral damage during B cell gene diversification. In aim 1, we test the notion that the RNA-guided recruitment of AID is critical fo CSR in vivo. In aim 2, we examine if RNA-guided AID recruitment serves to shelter the B cell genome from collateral AID-induced DNA damage. In aim 3, we design chimeric RNA molecules for ectopic targeting of AID. These studies will have far-reaching implications into our fundamental understanding of both immunity and how simple aberrations in the process could lead to B cell lymphomas.
描述(由申请人提供):DNA 双链断裂 (DSB) 是细胞中发生的最具毒性的损伤之一,未修复的 DSB 要么导致细胞死亡,要么参与染色体易位,而染色体易位是多种肿瘤的标志。尽管 DSB 具有毒性,但在类别转换重组 (CSR) 的免疫球蛋白 (Ig) 基因多样化过程中,DSB 是故意的。 DNA 脱氨酶 AID(激活诱导胞苷脱氨酶)对于 DSB 的产生至关重要。区域(以及与 Ig 基因相关的可变区基因片段)是主要靶标,AID 有可能在非 Ig 基因(包括癌基因)上诱导 DSB。大量成熟 B 细胞淋巴瘤个体发育背后的主要病变 尽管 AID 靶向与免疫和癌症相关,但 AID 特异性的分子机制尚未完全阐明。该提议测试了这样的假设:转换转录物不仅将 AID 招募到 S 区域以促进 CSR,而且还将 AID 与其他基因组区域隔离以防止 B 细胞基因过程中的附带损伤。在目标 1 中,我们测试了 RNA 引导的 AID 募集对于体内 CSR 至关重要的概念。在目标 3 中,我们设计了用于 AID 异位靶向的嵌合 RNA 分子,这些研究将对我们对免疫以及该过程中的简单畸变如何导致 B 细胞淋巴瘤的基本理解产生深远的影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jayanta Chaudhuri其他文献
Jayanta Chaudhuri的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jayanta Chaudhuri', 18)}}的其他基金
RNA-directed targeting of AID in immunity and cancer
RNA定向靶向AID在免疫和癌症中的作用
- 批准号:
10664029 - 财政年份:2016
- 资助金额:
$ 42.85万 - 项目类别:
RNA-directed targeting of AID in immunity and genomic integrity
RNA 引导的 AID 免疫和基因组完整性靶向
- 批准号:
9095773 - 财政年份:2016
- 资助金额:
$ 42.85万 - 项目类别:
RNA-directed targeting of AID in immunity and cancer
RNA定向靶向AID在免疫和癌症中的作用
- 批准号:
10664029 - 财政年份:2016
- 资助金额:
$ 42.85万 - 项目类别:
RNA-directed targeting of AID in immunity and cancer
RNA定向靶向AID在免疫和癌症中的作用
- 批准号:
10530805 - 财政年份:2016
- 资助金额:
$ 42.85万 - 项目类别:
Mechanistic Elucidation of Class Switch Recombination and Somatic Hypermutation
类别转换重组和体细胞超突变的机制阐明
- 批准号:
10551335 - 财政年份:2009
- 资助金额:
$ 42.85万 - 项目类别:
Elucidation of Immunoglobulin Class Switch Recombination
免疫球蛋白类别转换重组的阐明
- 批准号:
9172233 - 财政年份:2009
- 资助金额:
$ 42.85万 - 项目类别:
Mechanistic Elucidation of Class Switch Recombination and Somatic Hypermutation
类别转换重组和体细胞超突变的机制阐明
- 批准号:
10348783 - 财政年份:2009
- 资助金额:
$ 42.85万 - 项目类别:
ELUCIDATION OF IMMUNOGLOBULIN CLASS SWITCH RECOMBINATION AND SOMATIC HYPERMUTATIO
免疫球蛋白类别转换重组和体细胞超突变的阐明
- 批准号:
8284486 - 财政年份:2009
- 资助金额:
$ 42.85万 - 项目类别:
ELUCIDATION OF IMMUNOGLOBULIN CLASS SWITCH RECOMBINATION AND SOMATIC HYPERMUTATIO
免疫球蛋白类别转换重组和体细胞超突变的阐明
- 批准号:
8500117 - 财政年份:2009
- 资助金额:
$ 42.85万 - 项目类别:
ELUCIDATION OF IMMUNOGLOBULIN CLASS SWITCH RECOMBINATION AND SOMATIC HYPERMUTATIO
免疫球蛋白类别转换重组和体细胞超突变的阐明
- 批准号:
7870360 - 财政年份:2009
- 资助金额:
$ 42.85万 - 项目类别:
相似国自然基金
线上民宿房东亲和力对房客预定行为的影响机制研究——基于多源异构数据视角
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
估计和解释序列变体对蛋白质稳定性、结合亲和力以及功能的影响
- 批准号:31701136
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
RGS19对嗜酸细胞性食管炎FcεRI信号传导通路的影响及其作用机制的研究
- 批准号:81500502
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
人B组腺病毒纤毛蛋白与DSG2受体亲和力的差异及其对病毒致病力的影响研究
- 批准号:31570163
- 批准年份:2015
- 资助金额:62.0 万元
- 项目类别:面上项目
TNFalpha-OPG相互作用对骨代谢的影响
- 批准号:30340052
- 批准年份:2003
- 资助金额:9.0 万元
- 项目类别:专项基金项目
相似海外基金
Investigating protective adaptive immune responses to influenza antigens using human tonsil organoids
使用人扁桃体类器官研究对流感抗原的保护性适应性免疫反应
- 批准号:
10733719 - 财政年份:2023
- 资助金额:
$ 42.85万 - 项目类别:
HIPK1: a new immunomodulatory target for SLE
HIPK1:SLE 的新免疫调节靶点
- 批准号:
10647292 - 财政年份:2023
- 资助金额:
$ 42.85万 - 项目类别:
CD37 as a Regulator of Platelet Patho(Physiological) Responses
CD37 作为血小板病理(生理)反应的调节剂
- 批准号:
10638254 - 财政年份:2023
- 资助金额:
$ 42.85万 - 项目类别:
Identifying and exploiting therapeutic vulnerabilities of tumor-host interactions that drive bone-to-meninges breast cancer metastasis
识别和利用导致骨到脑膜乳腺癌转移的肿瘤与宿主相互作用的治疗脆弱性
- 批准号:
10826488 - 财政年份:2023
- 资助金额:
$ 42.85万 - 项目类别:
3D Methodology for Interpreting Disease-Associated Genomic Variation in RAG2
解释 RAG2 中疾病相关基因组变异的 3D 方法
- 批准号:
10724152 - 财政年份:2023
- 资助金额:
$ 42.85万 - 项目类别: